JP Morgan Chase’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Sell |
250,735
-1,021
| -0.4% | -$52K | ﹤0.01% | 2487 |
|
|
2025
Q4 | $12.5M | Buy |
251,756
+80,471
| +47% | +$3.91M | ﹤0.01% | 2482 |
|
|
2025
Q3 | $8.19M | Sell |
171,285
-143,816
| -46% | -$5.79M | ﹤0.01% | 2901 |
|
|
2025
Q2 | $9.93M | Sell |
315,101
-194,259
| -38% | -$6.23M | ﹤0.01% | 2554 |
|
|
2025
Q1 | $16.7M | Buy |
509,360
+211,550
| +71% | +$7.5M | ﹤0.01% | 2064 |
|
|
2024
Q4 | $10.8M | Buy |
297,810
+44,414
| +18% | +$1.56M | ﹤0.01% | 2626 |
|
|
2024
Q3 | $7.9M | Buy |
253,396
+73,118
| +41% | +$2.28M | ﹤0.01% | 2818 |
|
|
2024
Q2 | $4.82M | Sell |
180,278
-16,836
| -9% | -$488K | ﹤0.01% | 3062 |
|
|
2024
Q1 | $6.72M | Buy |
197,114
+41,361
| +27% | +$1.23M | ﹤0.01% | 2834 |
|
|
2023
Q4 | $4.51M | Buy |
155,753
+21,930
| +16% | +$581K | ﹤0.01% | 3183 |
|
|
2023
Q3 | $3.69M | Sell |
133,823
-7,861
| -6% | -$239K | ﹤0.01% | 3069 |
|
|
2023
Q2 | $4.26M | Sell |
141,684
-70,087
| -33% | -$2.45M | ﹤0.01% | 2996 |
|
|
2023
Q1 | $7.67M | Sell |
211,771
-31,084
| -13% | -$1.2M | ﹤0.01% | 2507 |
|
|
2022
Q4 | $8.66M | Buy |
242,855
+32,449
| +15% | +$1.13M | ﹤0.01% | 2385 |
|
|
2022
Q3 | $7.12M | Sell |
210,406
-42,689
| -17% | -$1.39M | ﹤0.01% | 2434 |
|
|
2022
Q2 | $7.32M | Buy |
253,095
+181,830
| +255% | +$5.21M | ﹤0.01% | 2426 |
|
|
2022
Q1 | $2.3M | Buy |
71,265
+11,443
| +19% | +$351K | ﹤0.01% | 3641 |
|
|
2021
Q4 | $1.75M | Buy |
59,822
+6,948
| +13% | +$211K | ﹤0.01% | 3951 |
|
|
2021
Q3 | $1.41M | Buy |
52,874
+451
| +0.9% | +$12.1K | ﹤0.01% | 4051 |
|
|
2021
Q2 | $1.61M | Buy |
52,423
+3,573
| +7% | +$110K | ﹤0.01% | 3945 |
|
|
2021
Q1 | $1.28M | Sell |
48,850
-20,928
| -30% | -$585K | ﹤0.01% | 4043 |
|
|
2020
Q4 | $1.75M | Buy |
69,778
+31,789
| +84% | +$684K | ﹤0.01% | 3568 |
|
|
2020
Q3 | $792K | Sell |
37,989
-6,175
| -14% | -$140K | ﹤0.01% | 3765 |
|
|
2020
Q2 | $1.05M | Buy |
44,164
+6,965
| +19% | +$154K | ﹤0.01% | 3483 |
|
|
2020
Q1 | $669K | Sell |
37,199
-2,679
| -7% | -$56.3K | ﹤0.01% | 3669 |
|
|
2019
Q4 | $946K | Buy |
39,878
+21,276
| +114% | +$517K | ﹤0.01% | 3909 |
|
|
2019
Q3 | $511K | Buy |
18,602
+2,218
| +14% | +$65.7K | ﹤0.01% | 4165 |
|
|
2019
Q2 | $524K | Buy |
16,384
+2,369
| +17% | +$81.2K | ﹤0.01% | 4216 |
|
|
2019
Q1 | $491K | Sell |
14,015
-37,867
| -73% | -$1.41M | ﹤0.01% | 4216 |
|
|
2018
Q4 | $1.72M | Sell |
51,882
-90,996
| -64% | -$3.91M | ﹤0.01% | 3394 |
|
|
2018
Q3 | $7.19M | Sell |
142,878
-56,561
| -28% | -$2.79M | ﹤0.01% | 2464 |
|
|
2018
Q2 | $11.9M | Sell |
199,439
-262,147
| -57% | -$13.6M | ﹤0.01% | 1999 |
|
|
2018
Q1 | $21.1M | Buy |
461,586
+288,059
| +166% | +$12M | ﹤0.01% | 1463 |
|
|
2017
Q4 | $6.92M | Buy |
173,527
+172,017
| +11,392% | +$6.8M | ﹤0.01% | 2409 |
|
|
2017
Q3 | $59K | Sell |
1,510
-49,957
| -97% | -$2.16M | ﹤0.01% | 4434 |
|
|
2017
Q2 | $2.22M | Sell |
51,467
-25,964
| -34% | -$924K | ﹤0.01% | 2982 |
|
|
2017
Q1 | $2.42M | Sell |
77,431
-16,190
| -17% | -$434K | ﹤0.01% | 2930 |
|
|
2016
Q4 | $2.36M | Buy |
93,621
+67,146
| +254% | +$1.5M | ﹤0.01% | 2957 |
|
|
2016
Q3 | $654K | Buy |
26,475
+26,390
| +31,047% | +$597K | ﹤0.01% | 3307 |
|
|
2016
Q2 | $2K | Sell |
85
-188,105
| -100% | -$3.34M | ﹤0.01% | 4611 |
|
|
2016
Q1 | $2.87M | Buy |
188,190
+85
| +0% | +$1.11K | ﹤0.01% | 2520 |
|
|
2015
Q4 | $2.53M | Buy |
+188,105
| New | +$2.91M | ﹤0.01% | 2637 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
